- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
Weekly Investor Report
Tianjin TEDA Biomedical Engineering Company Limited ยท Basic Materials ยท Agricultural Inputs
Mixed setup
The weekly trend is not active. Price is 9.8% above the Trend Line and sits at 38.0% of its 52-week range. The latest completed week returned -5.6%, after a 75.9% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Next-week expectancy is negative at 42.40% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Where price isโand whether the trend supports it
The weekly trend is not active. Price is 9.8% above the Trend Line and sits at 38.0% of its 52-week range. The latest completed week returned -5.6%, after a 75.9% four-week move.
52-week price path
Price vs Trend Line and Fair ValueIs real participation confirming the move?
Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price directionActivity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
12-week confirmation
No recent accumulation markers. No reversal markers.
Is performance persistentโand is the stock leading?
Performance is 75.9% over four weeks, 51.8% over 12 weeks, and -46.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Activity pressure vs relative leadership
What investors are paying forโand the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
No recent insider transactions are stored for this company.
Weighted news tone is neutral across 0 relevant articles.
0 positive ยท 0 neutral ยท 0 negativeActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeksWhat can move the sharesโand how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
Shape of recent returns
Is this stock leadingโor simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
Four-week leaders
Four-week leaders
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Trend, activity pressure, participation, and risk combine to a 28/100 tape read.
Indicator analysis17/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.17; No reversal markers Next-Week ExpectancyNegative 42.40%Next-week expectancy is negative with a 42.40% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 28 Aug 2026 | 0.255 HKD | -5.6% | 0.2323 HKD | 0.2509 HKD | 0.95 | -10.56 | 2.0M | Off |
| 21 Aug 2026 | 0.27 HKD | 0.0% | 0.2355 HKD | 0.2498 HKD | 0.62 | -8.27 | 6.4M | Off |
| 14 Aug 2026 | 0.27 HKD | 100.0% | 0.2363 HKD | 0.2485 HKD | 0.09 | -6.31 | 15.0M | Off |
| 7 Aug 2026 | 0.135 HKD | -6.9% | 0.2378 HKD | 0.2472 HKD | -0.53 | -54.77 | 1.0M | Off |
| 31 Jul 2026 | 0.145 HKD | 0.0% | 0.244 HKD | 0.2468 HKD | -0.71 | -52.84 | 2.2M | Off |
| 24 Jul 2026 | 0.145 HKD | 3.6% | 0.2493 HKD | 0.2463 HKD | -0.95 | -52.09 | 0 | Off |
| 17 Jul 2026 | 0.14 HKD | -6.7% | 0.2551 HKD | 0.2458 HKD | -1.12 | -53.93 | 295.0K | Off |
| 10 Jul 2026 | 0.15 HKD | 10.3% | 0.2605 HKD | 0.2453 HKD | -1.22 | -50.89 | 0 | Off |
| 3 Jul 2026 | 0.136 HKD | -2.2% | 0.2655 HKD | 0.2447 HKD | -1.29 | -54.90 | 65.0K | Off |
| 26 Jun 2026 | 0.139 HKD | -9.2% | 0.2709 HKD | 0.2443 HKD | -1.36 | -53.28 | 30.0K | Off |
| 19 Jun 2026 | 0.153 HKD | -8.4% | 0.2783 HKD | 0.2438 HKD | -1.35 | -52.00 | 660.0K | Off |
| 12 Jun 2026 | 0.167 HKD | -0.6% | 0.2857 HKD | 0.2433 HKD | -1.41 | -50.07 | 1.5M | Off |
| 5 Jun 2026 | 0.168 HKD | 37.7% | 0.293 HKD | 0.2427 HKD | -1.50 | -50.93 | 245.0K | Off |
| 29 May 2026 | 0.122 HKD | -43.3% | 0.3005 HKD | 0.2421 HKD | -1.45 | -65.17 | 8.6M | Off |
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.